Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.
| Author | :
|
|---|---|
| Abstract | :
In the primary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) trial, now published in the Journal, we report that the daily use of aspirin did not provide a benefit with regard to the primary end point of disability-free survival among older adults. A numerically higher rate of the secondary end point of death from any cause was observed with aspirin than with placebo. |
| Year of Publication | :
2018
|
| Journal | :
The New England journal of medicine
|
| Volume | :
379
|
| Issue | :
16
|
| Number of Pages | :
1519-1528
|
| Date Published | :
2018
|
| ISSN Number | :
0028-4793
|
| URL | :
https://www.nejm.org/doi/10.1056/NEJMoa1803955?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dwww.ncbi.nlm.nih.gov
|
| DOI | :
10.1056/NEJMoa1803955
|
| Short Title | :
N Engl J Med
|
| Download citation |